# TRACK RECORD OF SUCCESS - From ecoNugenics to Eliaz Therapeutics | Eliaz Therapeutics

- Canonical URL: https://wefunder.com/feed/184834
- Entity ID: wefunder:feed_item:184834
- Published at: 2025-08-18 10:49:03 UTC
- Updated at: 2025-08-19 08:35:16 UTC

## Author
Dr. Isaac Eliaz (MD)

## Subject
Eliaz Therapeutics

## Content
To our valued Wefunder community,In 2023, a leading private equity firm acquired my previous venture, ecoNugenics, after I had spent three decades building a company that helped hundreds of thousands of patients worldwide.At ecoNugenics, we achieved something remarkable: growing from a research-driven startup into a global leader in natural medicine, with clinically validated products adopted by top medical institutions.Now, at Eliaz Therapeutics, I’ve reunited with the key team members who drove that success. Our COO Anat Stern — who led ecoNugenics to a successful exit as CEO — brings her proven playbook for scaling healthcare innovations.Beyond our core team, we’ve attracted world-class talent and investors, including:Dr. Susan Alpert, former FDA Director of Device EvaluationDr. Glenn Chertow, Chief of Nephrology at StanfordNathan Crane, bestselling author and award-winning natural health researcherTogether, we’re applying the proven blueprint that built ecoNugenics to an even greater opportunity: transforming the $62 billion U.S. sepsis care market.FDA Breakthrough Device Designation for XGal-3® and the milestone of enrolling our first patient in diagnostic trials, we are well positioned to deliver significant value — both for patients and for the investors who join us on this journey.💡 Investment opportunities start at $250 and take just a few minutes to complete. Learn more here. Yours, Isaac